HighPoint Advisor Group LLC Grows Stock Holdings in Intuitive Surgical, Inc. $ISRG

HighPoint Advisor Group LLC boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 112.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 15,205 shares of the medical equipment provider’s stock after buying an additional 8,052 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Intuitive Surgical were worth $6,800,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of ISRG. Tobam raised its position in shares of Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 40 shares in the last quarter. Kilter Group LLC purchased a new position in Intuitive Surgical in the second quarter valued at approximately $27,000. Greykasell Wealth Strategies Inc. acquired a new stake in Intuitive Surgical during the third quarter worth approximately $27,000. Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth approximately $30,000. Finally, Guerra Advisors Inc acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $37,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $435,000.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Henry L. Charlton sold 13,731 shares of the stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares of the company’s stock, valued at $1,772,480. This represents a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 73,616 shares of company stock worth $40,929,575. 0.70% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Royal Bank Of Canada lifted their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 17th. Barclays set a $712.00 target price on Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. Raymond James Financial upped their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. BTIG Research reaffirmed a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, HSBC increased their price objective on Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. Two research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $620.41.

Intuitive Surgical Trading Down 0.1%

Intuitive Surgical stock opened at $478.49 on Thursday. The stock has a 50 day moving average of $553.29 and a two-hundred day moving average of $510.97. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08. The stock has a market capitalization of $171.53 billion, a price-to-earnings ratio of 60.65, a PEG ratio of 3.72 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the business earned $2.21 earnings per share. The company’s quarterly revenue was up 18.8% compared to the same quarter last year. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.